Discover the rheumatoid arthritis drugs market's expansion to US$56.62 billion by 2033 with 6.8% CAGR. Key insights on DMARDs' 45.1% share, synthetic and biologic segments, and patient-centric trends fueled by digital tools like ultrasound monitoring and targeted therapies. https://au.finance.yahoo.com/news/rheumatoid-arthritis-drugs-market-size-155000726.html